β-Blocker use for patients with or at risk for coronary artery disease--reply

Comment

Sripal Bangalore et al. JAMA. 2013.

. 2013 Feb 6;309(5):439-40.

doi: 10.1001/jama.2012.128872.

No abstract available

Comment on

β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.
Bangalore S, Steg G, Deedwania P, Crowley K, Eagle KA, Goto S, Ohman EM, Cannon CP, Smith SC, Zeymer U, Hoffman EB, Messerli FH, Bhatt DL; REACH Registry Investigators. Bangalore S, et al. JAMA. 2012 Oct 3;308(13):1340-9. doi: 10.1001/jama.2012.12559. JAMA. 2012. PMID: 23032550
β-Blocker use for patients with or at risk for coronary artery disease.
Shang C. Shang C. JAMA. 2013 Feb 6;309(5):438. doi: 10.1001/jama.2012.128869. JAMA. 2013. PMID: 23385258 No abstract available.
β-Blocker use for patients with or at risk for coronary artery disease.
Rutten FH, Groenwold RH. Rutten FH, et al. JAMA. 2013 Feb 6;309(5):438-9. doi: 10.1001/jama.2012.128865. JAMA. 2013. PMID: 23385259 No abstract available.
β-Blocker use for patients with or at risk for coronary artery disease.
Costagliola D, Hernán MA. Costagliola D, et al. JAMA. 2013 Feb 6;309(5):439. doi: 10.1001/jama.2012.128862. JAMA. 2013. PMID: 23385260 No abstract available.